Delivery Order SPE2DB20D1100-SPE2DB25FB2J2
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,175.40, is for the delivery of INFUVITE PEDIATRIC VIAL 5ML, a medical product. The contract is a Firm Fixed Price (FFP) type and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and this award is part of a larger...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,081.84, is for the delivery of INFUVITE PEDIATRIC VIAL 5ML, a pharmaceutical product, with a completion date of November 7, 2024. The contract is a firm-fixed-price delivery order, and it is not designated as a set-aside. Amerisourcebergen Drug Corp is a for-profit organization...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of INFUVITE PEDIATRIC VIAL 5ML, a critical medical product, to support federal healthcare programs. The contract has a ceiling value of $4,101.77 and is a firm fixed-price delivery order, without any set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,348.42 contract is for the supply of INFUVITE PEDIATRIC VIAL 5ML, a pharmaceutical product. The award has an ultimate completion date of October 28, 2024 and is a firm fixed-price delivery order contract. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of INFUVITE PEDIATRIC VIAL 5ML. The contract has a ceiling value of $16,121.10 and an ultimate completion date of August 5, 2024. It is a firm-fixed-price contract, with no set-aside designation. Amerisourcebergen has been a significant supplier of pharmaceutical products and medical supplies to various federal agencies, including...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of INFUVITE PEDIATRIC VIAL 5ML pharmaceutical products. The contract has a ceiling value of $21,151.36 and runs through September 5, 2024. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $24,909.65, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INFUVITE PEDIATRIC VIAL 5ML, a medical product classified under the National Stock Number 4566858370. The contract is a Firm Fixed Price Delivery Order with a completion date of January 8, 2025. This award is part of a larger Indefinite Delivery Contract (IDC)...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INFUVITE PEDIATRIC VIAL 5ML, a medical product, with a period of performance through July 2, 2025 and a ceiling value of $20,090.52. The contract is structured as a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition....
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp., a major pharmaceutical distribution company, for the supply of INFUVITE PEDIATRIC VIAL 5ML medical products. The contract has a firm fixed price of $9,194.69 and a completion date of May 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,616.01, is for the delivery of Infuvite Pediatric Vial 5ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of August 8, 2022. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FB2J2Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,072.44, is for the delivery of INFUVITE PEDIATRIC VIAL 5ML, a pharmaceutical product. The contract is a Firm Fixed Price type and has an ultimate completion date of March 20, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. There is no set-aside designation for this specific contract award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.1k | 3/19/25 |